Tirzepatide, a newer dual agonist of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), has shown even greater weight loss, crucial for reducing the risk of T2D and improving health outcomes in those with obesity or T2D
This makes T-Shape 2 a valuable tool for individuals looking to slim stubborn areas that have been resistant to diet and exercise alone
If your plan doesn't cover Zepbound, file a formulary exception with your provider's help
Molecular signatures of premature aging in major depression and substance use disorders
Its the kind of change patients actually feel in their daily lives
Your patients will also get access to our powerful weight-loss platform featuring daily, bite-sized lessons, human coaching with AI insights, and a supportive community of Noomers just like them